These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 7677387)

  • 1. Clinical pharmacology of drugs acting on imidazoline and adrenergic receptors. Studies with clonidine, moxonidine, rilmenidine, and atenolol.
    Reid JL; Panfilov V; MacPhee G; Elliott HL
    Ann N Y Acad Sci; 1995 Jul; 763():673-8. PubMed ID: 7677387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why imidazoline receptor modulator in the treatment of hypertension?
    Schäfer SG; Kaan EC; Christen MO; Löw-Kröger A; Mest HJ; Molderings GJ
    Ann N Y Acad Sci; 1995 Jul; 763():659-72. PubMed ID: 7677385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. I1 imidazoline agonists. General clinical pharmacology of imidazoline receptors: implications for the treatment of the elderly.
    Prichard BN; Graham BR
    Drugs Aging; 2000 Aug; 17(2):133-59. PubMed ID: 10984201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist.
    Ernsberger P; Haxhiu MA; Graff LM; Collins LA; Dreshaj I; Grove DL; Graves ME; Schäfer SG; Christen MO
    Cardiovasc Drugs Ther; 1994 Mar; 8 Suppl 1():27-41. PubMed ID: 8068578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central I1-imidazoline receptors as targets of centrally acting antihypertensive drugs. Clinical pharmacology of moxonidine and rilmenidine.
    Van Zwieten PA; Peters SL
    Ann N Y Acad Sci; 1999 Jun; 881():420-9. PubMed ID: 10415946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative importance of central imidazoline receptors for the antihypertensive effects of moxonidine and rilmenidine.
    Chan CK; Head GA
    J Hypertens; 1996 Jul; 14(7):855-64. PubMed ID: 8818924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits.
    Chan CK; Sannajust F; Head GA
    J Pharmacol Exp Ther; 1996 Feb; 276(2):411-20. PubMed ID: 8632304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central imidazoline (I1) receptors as targets of centrally acting antihypertensives: moxonidine and rilmenidine.
    van Zwieten PA
    J Hypertens; 1997 Feb; 15(2):117-25. PubMed ID: 9469786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of imidazoline-preferring receptors in the cardiovascular actions of chronically administered moxonidine, rilmenidine and clonidine in conscious rabbits.
    Parkin ML; Godwin SJ; Head GA
    J Hypertens; 2003 Jan; 21(1):167-78. PubMed ID: 12544449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs acting on imidazoline receptors: a review of their pharmacology, their use in blood pressure control and their potential interest in cardioprotection.
    Bousquet P; Feldman J
    Drugs; 1999 Nov; 58(5):799-812. PubMed ID: 10595861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of rilmenidine and atenolol on mental stress, dynamic exercise and autonomic function in mild to moderate hypertension.
    Panfilov V; Morris AD; Donnelly R; Scemama M; Reid JL
    Br J Clin Pharmacol; 1995 Dec; 40(6):563-9. PubMed ID: 8703663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine.
    Szabo B; Urban R
    Arzneimittelforschung; 1997 Sep; 47(9):1009-15. PubMed ID: 9342413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Centrally acting imidazoline I1-receptor agonists: do they have a place in the management of hypertension?
    van Zwieten PA
    Am J Cardiovasc Drugs; 2001; 1(5):321-6. PubMed ID: 14728014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of imidazoline-preferring receptors in regulation of sympathetic tone.
    Sannajust F; Head GA
    Am J Cardiol; 1994 Dec; 74(13):7A-19A. PubMed ID: 7998588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The imidazoline receptor in control of blood pressure by clonidine and allied drugs.
    Reis DJ; Piletz JE
    Am J Physiol; 1997 Nov; 273(5):R1569-71. PubMed ID: 9374795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central imidazoline- and alpha 2-receptors involved in the cardiovascular actions of centrally acting antihypertensive agents.
    Head GA
    Ann N Y Acad Sci; 1999 Jun; 881():279-86. PubMed ID: 10415926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. I1 receptors, cardiovascular function, and metabolism.
    Bousquet P
    Am J Hypertens; 2001 Nov; 14(11 Pt 2):317S-321S. PubMed ID: 11721890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imidazoline receptor agonist drugs: a new approach to the treatment of systemic hypertension.
    Yu A; Frishman WH
    J Clin Pharmacol; 1996 Feb; 36(2):98-111. PubMed ID: 8852385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the baroreceptor-heart rate reflex effects of moxonidine, rilmenidine and clonidine in conscious rabbits.
    Godwin SJ; Tortelli CF; Parkin ML; Head GA
    J Auton Nerv Syst; 1998 Oct; 72(2-3):195-204. PubMed ID: 9851569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of imidazoline receptors in the cardiovascular actions of centrally acting antihypertensive agents.
    Head GA
    Ann N Y Acad Sci; 1995 Jul; 763():531-40. PubMed ID: 7677371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.